Endothelin inhibitors for advanced prostate cancer
Citation:
Foley R, Keane J, O Mathuna DP, Hollywood D., Endothelin inhibitors for advanced prostate cancer, Cochrane Database of Systematic Reviews, 8, CD009193, 2011Download Item:
Abstract:
This is the protocol for a review and there is no abstract. The objectives are as follows:
Our review aims to determine the effectiveness and adverse effects of endothelin inhibitors for advanced prostate cancer.
The primary objectives are to assess the effect of endothelin inhibitors on overall survival, prostate cancer-speci?c survival, and
progression-free survival.
The secondary objectives are to determine:
1. the frequency of adverse events;
2. the effect of treatment on target lesions identi?ed by radiological imaging;
3. the effect of treatment on molecular biomarkers, including PSA and bone alkaline phosphatase;
4. the impact on quality of life.
Sponsor
Grant Number
Health Research Board
Author's Homepage:
http://people.tcd.ie/edgarrhttp://people.tcd.ie/dhlywood
Description:
PUBLISHED
Author: HOLLYWOOD, DONAL; FOLEY, RUTH
Publisher:
John WileyType of material:
Journal ArticleCollections
Series/Report no:
Cochrane Database of Systematic Reviews;8;
CD009193;
Availability:
Full text availableKeywords:
Oncology, Prostate cancerMetadata
Show full item recordLicences: